Cargando…

Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup

Detalles Bibliográficos
Autores principales: Garrido, Pilar, Chouaki, Nadia, Serke, Monika, Giraud, Philippe, Ricardi, Umberto, Vallejo, Carmen, Visseren-Grul, Carla, Soldatenkova, Victoria, Novello, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ESMO Open 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519800/
https://www.ncbi.nlm.nih.gov/pubmed/28761728
http://dx.doi.org/10.1136/esmoopen-2016-000141
_version_ 1783251697449041920
author Garrido, Pilar
Chouaki, Nadia
Serke, Monika
Giraud, Philippe
Ricardi, Umberto
Vallejo, Carmen
Visseren-Grul, Carla
Soldatenkova, Victoria
Novello, Silvia
author_facet Garrido, Pilar
Chouaki, Nadia
Serke, Monika
Giraud, Philippe
Ricardi, Umberto
Vallejo, Carmen
Visseren-Grul, Carla
Soldatenkova, Victoria
Novello, Silvia
author_sort Garrido, Pilar
collection PubMed
description
format Online
Article
Text
id pubmed-5519800
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher ESMO Open
record_format MEDLINE/PubMed
spelling pubmed-55198002017-07-31 Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup Garrido, Pilar Chouaki, Nadia Serke, Monika Giraud, Philippe Ricardi, Umberto Vallejo, Carmen Visseren-Grul, Carla Soldatenkova, Victoria Novello, Silvia ESMO Open Correspondence ESMO Open 2017-03-09 /pmc/articles/PMC5519800/ /pubmed/28761728 http://dx.doi.org/10.1136/esmoopen-2016-000141 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Correspondence
Garrido, Pilar
Chouaki, Nadia
Serke, Monika
Giraud, Philippe
Ricardi, Umberto
Vallejo, Carmen
Visseren-Grul, Carla
Soldatenkova, Victoria
Novello, Silvia
Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
title Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
title_full Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
title_fullStr Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
title_full_unstemmed Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
title_short Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
title_sort pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous nsclc: results by age subgroup
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519800/
https://www.ncbi.nlm.nih.gov/pubmed/28761728
http://dx.doi.org/10.1136/esmoopen-2016-000141
work_keys_str_mv AT garridopilar pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup
AT chouakinadia pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup
AT serkemonika pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup
AT giraudphilippe pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup
AT ricardiumberto pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup
AT vallejocarmen pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup
AT visserengrulcarla pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup
AT soldatenkovavictoria pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup
AT novellosilvia pemetrexedcisplatinwithconcurrentthoracicradiationafterpemetrexedcisplatininductioninpatientswithunresectablelocallyadvancednonsquamousnsclcresultsbyagesubgroup